📰 Both Kaplan Meier News

Both Kaplan Meier News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Both Kaplan Meier. Real-time updates on events, politics, business and more.

SGLT2 Inhibitor Use in Stage 5 CKD Cuts Risks for Cardiovascular, Kidney Events

June 4, 2024

This study is among the first to report outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy in stage 5 chronic kidney disease.

Source: clinicaladvisor.com

May 2, 2024

This study is among the first to report outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy in stage 5 chronic kidney disease (CKD).

Source: endocrinologyadvisor.com

May 1, 2024

This study is among the first to report outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy in stage 5 chronic kidney disease.

Source: clinicaladvisor.com

April 30, 2024

This study is among the first to report outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy in stage 5 chronic kidney disease (CKD).

Source: renalandurologynews.com